While there are no FDA-approved drugs to specifically treat COVID-19, clinical trials are taking place across the country. Just this week, hospitals in New York, where 33,000 cases have been confirmed, began clinical trials using a combination of the anti-malaria drug hydroxychloroquine and the antibiotic azithromycin.
At the same time, a San Diego based telehealth company is announcing it has begun to prescribe the experimental treatment to patients who meet certain criteria.
[ Ссылка ]
